170394 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates; Assays involving proteins of known structure or function as defined in the subgroups; Details Keratin; Cytokeratin
PROLIFERATION ASSAY FOR FIXED SOLID TUMORS
#2APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS
#3IDENTIFYING CANDIDATE CELLS USING IMAGE ANALYSIS WITH OVERLAP THRESHOLDS
#4CHROMOGENIC MULTIPLEXING METHODS AND SYSTEMS FOR IDENTIFYING A CANCER OF UNKNOWN PRIMARY ORIGIN
#5ANTI-TUMOUR RESPONSES TO CYTOKERATINS
#6Methods for Sample Quality Assessment
#7Methods of Identifying and Treating Progressive Colorectal Cancer
#8Method for detecting and subtyping inflammatory intestinal diseases
#9RENAL CELL POPULATIONS AND USES THEREOF
#10METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION TO IMPROVE THE FERTILIZER USAGE EFFICIENCY IN SOYBEAN
#11USE OF MARKERS INCLUDING FILAMIN A IN THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
#12METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION TO ENHANCE THE YIELD AND QUALITY OF CUCUMBER FRUITS
#13METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION TO ENAHNCE THE FLAVOR OF TEA LEAVES
#14METHODS AND SYSTEMS FOR PREDICTING RESPONSE TO PD-1 AXIS DIRECTED THERAPEUTICS IN COLORECTAL TUMORS WITH DEFICIENT MISMATCH REPAIR
#15METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION UPON COTTON TO ENHANCE DROUGHT-TOLERANCE
#16KIDNEY-ON-A-CHIP COMPRISING RENAL TUBULE CULTURE PART AND INTERSTITIUM CULTURE PART
#17METHODS FOR THE TREATMENT OF HUNTER SYNDROME
#18K17 AS A BIOMARKER FOR TUMOR RESPONSE TO IMMUNOTHERAPY
#19MOLECULAR MARKER FOR DETERMINING VERY-EARLY-STAGE ONSET RISK OF GASTRIC CANCER AND EVALUATING PROGRESSION RISK OF PRE-CANCEROUS LESION OF GASTRIC CANCER, AND USE THEREOF IN DIAGNOSTIC KIT
#20IDENTIFYING CANDIDATE CELLS USING IMAGE ANALYSIS WITH OVERLAP THRESHOLDS
#21EX VIVO MODEL OF INFLAMED HUMAN SKIN AND USES THEREOF FOR SCREENING ANTI-INFLAMMATORY COMPOUNDS
#22FILAMIN A BINDING PROTEINS AND USES THEREOF
#23CIRCULATING TUMOR CELL DIAGNOSTICS FOR BIOMARKERS PREDICTIVE OF RESISTANCE TO ANDROGEN RECEPTOR (AR) TARGETED THERAPIES
#24ANTIBODIES AND METHODS FOR THE DETECTION OF CELL DEATH
#25Method for generating training data based on immunohistochemistry and storage device
#26USE OF PHOSPHO-KERATIN 8 AS A BIOMARKER FOR DETECTING DIVIDING CANCER CELL
#27DETECTION OF BIOMARKERS USEFUL IN DIAGNOSING CHRONIC ENTEROPATHIES IN CATS
#28SYSTEMS, METHODS AND ASSAYS FOR OUTLIER CLUSTERING UNSUPERVISED LEARNING AUTOMATED REPORT (OCULAR)
#29DETECTION OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) EXPRESSION ON CIRCULATING TUMOR CELLS (CTC)
#30Method for Determining Prognosis of Cancer
#31PROGNOSTIC VALUE OF BIOMARKERS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER HAVING STABLE DISEASE
#32KERATIN 17 AS A BIOMARKER FOR HEAD AND NECK CANCERS
#33KERATINS AS BIOMARKERS FOR CERVICAL CANCER AND SURVIVAL
#34METHOD OF ISOLATING CIRCULATING TUMOR CELLS
#35Method for Determining Prognosis of Cancer
#36CRISPR ASSAY FOR RAPID, ENHANCED SCREENING OF HPV-RELATED DISEASE
#37Identifying candidate cells using image analysis with overlap thresholds
#38Identifying candidate cells using image analysis with intensity levels
#39KERATIN 17 AS A BIOMARKER FOR BLADDER CANCER
#40RENAL CELL POPULATIONS AND USES THEREOF
#41Biomarker for diagnosing depression and uses thereof
#42Circulating tumor cell based biomarker composition for diagnosis and prognosis of metastatic prostate cancer
#43COLORECTAL CANCER SCREENING EXAMINATION AND EARLY DETECTION METHOD
#44Assaying Bladder-Associated Samples, Identifying and Treating Bladder-Associated Neoplasia, and Kits for Use Therein
#45CIRCULATING TUMOR CELL DIAGNOSTICS FOR BIOMARKERS PREDICTIVE OF RESISTANCE TO ANDROGEN RECEPTOR (AR) TARGETED THERAPIES
#46CIRCULATING TUMOR CELL DIAGNOSTICS FOR IDENTIFICATION OF RESISTANCE TO ANDROGEN RECEPTOR TARGETED THERAPIES
#47Antibodies and Methods for the Detection of Cell Death
#48DETECTION OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) EXPRESSION ON CIRCULATING TUMOR CELLS (CTC)
#49BIOMARKERS FOR UROTHELIAL CARCINOMA AND APPLICATIONS THEREOF
#50METHODS, USES AND KITS FOR MONITORING OR PREDICTING RESPONSE TO PERIODONTAL DISEASE TREATMENT
#51Filamin A binding proteins and uses thereof
#52IMMUNOLOGICAL COMPOSITION FOR DIAGNOSIS OF LUNG CANCER BY USING AUTOANTIBODY-ANTIGEN COMPLEX, DIAGNOSIS METHOD FOR LUNG CANCER BY USING SAME, AND LUNG CANCER DIAGNOSIS KIT COMPRISING SAME
#53Method for isolating cell nuclei having enhanced antigenicity from fixed cells or FFPE tissue section, and antigen activator and kit therefor
#54THE VOLUME-REGULATED ANION CHANNEL PROTEIN LRRC8A FOR USE IN ALTERING EPIDERMAL KERATINOCYTE DIFFERENTIATION
#55USE OF MARKERS INCLUDING FILAMIN A IN THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
#56Identifying candidate cells using image analysis
#57COMPUTER, INFORMATION PROCESSING METHOD, AND NETWORK SYSTEM
#58Keratin 17 as a biomarker for bladder cancer
#59COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS
#60Renal cell populations and uses thereof
#61Antibodies and methods for the detection of cell death
#62Novel Biomarkers for Sub-Typing Pancreatic Ductal Adenocarcinoma
#63NOVEL ASSAY
#64Method for Determining Prognosis of Cancer
#65Method of isolating circulating tumor cells
#66Method for the normalization of immunological tests and kits for performing such tests
#67Modelling system
#68Modelling system
#69Process for in vitro diagnosis of hepatic disorders
#70Method of predicting patient prognosis using rare cells
#71Identifying candidate cells using image analysis
#72Keratin 17 as a prognostic marker for pancreatic cancer
#73METHOD AND KIT FOR DIAGNOSING EPITHELIAL-TO-MESENCHYMAL TRANSITION (EMT) OF THE PERITONEUM
#74Methods of identifying an individual to be treated by chemotherapy based on cytokeratin-19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) marker molecules and related uses
#75COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS
#76Methods for determining prognosis of colorectal cancer
#77Filamin A binding proteins and uses thereof
#78Use of cabazitaxel in the treatment of prostate cancer
#79KERATINS AS BIOMARKERS FOR CERVICAL CANCER AND SURVIVAL
#80CIRCULATING TUMOR CELL DIAGNOSTICS FOR BIOMARKERS PREDICTIVE OF RESISTANCE TO ANDROGEN RECEPTOR (AR) TARGETED THERAPIES
#81USE OF MARKERS IN THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
#82Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
#83CIRCULATING TUMOR CELL ASSAY
#84Apparatus, method, and system for filter based cell capture and labeling with configurable laydown area
#85Counterstains for a biological sample
#86CIRCULATING TUMOR CELL DIAGNOSTICS FOR IDENTIFICATION OF RESISTANCE TO ANDROGEN RECEPTOR TARGETED THERAPIES
#87Renal cell populations and uses thereof
#88Antibodies and methods for the detection of cell death
#89KERATIN 17 AS A BIOMARKER FOR HEAD AND NECK CANCERS
#90METHODS FOR IMPROVING SKIN QUALITY
#91DETECTING PODOCYTE INJURY IN DIABETIC NEPHROPATHY AND GLOMERULONEPHRITIS
#92COMPOSITION AND METHOD FOR DETECTING MALIGNANT NEOPLASTIC DISEASE
#93Methods, kits, and systems for scoring the immune response to cancer
#94SRM/MRM assay for subtyping lung histology
#95Compositions and methods for prostate cancer analysis
#96Use of markers including filamin A in the diagnosis and treatment of prostate cancer
#97Ultra-small apoB-containing particles and methods of use thereof
#98METHOD FOR DETECTING PROSTATIC BASAL CELLS
#99KERATINS AS BIOMARKERS FOR CERVICAL CANCER AND SURVIVAL
#100Use of markers in the diagnosis and treatment of prostate cancer
#101METHODS FOR THE EARLY DETECTION OF COLORECTAL CANCER
#102METHODS FOR PREDICTING OVERALL SURVIVAL OF CANCER PATIENTS BASED ON NUMBERS OF CIRCULATING TUMOR CELLS
#103Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof
#104Method of isolating circulating tumor cells
#105SRM/MRM assay for subtyping lung histology
#106Systems And Methods For Early Detection Of Cervical Cancer By Multiplex Protein Biomarkers
#107Assay
#108DETECTION OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) EXPRESSION ON CIRCULATING TUMOR CELLS (CTC)
#109Methods for determining prognosis of colorectal cancer
#110Antibody cocktail
#111Diagnosis and risk stratification of bladder cancer
#112NOVEL BIOMARKERS FOR SUB-TYPING PANCREATIC DUCTAL ADENOCARCINOMA
#113RENAL CELL POPULATIONS AND USES THEREOF
#114METHOD FOR CATEGORIZING CIRCULATING TUMOR CELLS
#115CIRCULATING TUMOR CELL DIAGNOSTICS FOR BIOMARKERS PREDICTIVE OF RESISTANCE TO ANDROGEN RECEPTOR (AR) TARGETED THERAPIES
#116CIRCULATING TUMOR CELL ASSAY
#117Methods and kits for determining whether a patient with cirrhosis is at risk of having clinically significant portal hypertension
#118Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
#119METHOD FOR CHARACTERIZING CIRCULATING TUMOR CELLS, AND USE THEREOF IN DIAGNOSIS
#120ERG/TFF3/HMWCK triple immunostain for detection of prostate cancer
#121Ultra-small ApoB-containing particles and methods of use thereof
#122Devices and methods of cell capture and analysis
#123KRT19 stabilizing HER2 and use thereof
#124Systems and methods of detecting and demonstrating hair damage via evaluation of protein fragments
#125Marker comprising anti-CK8/18 complex autoantibody and its use for diagnosing cancer
#126Enrichment and identification of fetal cells in maternal blood and ligands for such use
#127Blood markers for diagnosing epithelium derived cancers and monoclonal antibodies thereof
#128COMPOSITIONS AND METHODS FOR PROSTATE CANCER ANALYSIS
#129Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same
#130METHODS FOR ASSESSING RISK OF BONE FRACTURE
#131OBJECTIVE, QUANTITATIVE METHOD TO PREDICT HISTOLOGICAL SUBTYPE IN NON-SMALL CELL LUNG CANCER
#132METHODS AND COMPOSITIONS FOR THE CLASSIFICATION OF NON-SMALL CELL LUNG CARCINOMA
#133BIOMARKER OF LUNG CANCER
#134Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
#135Method for Categorizing Circulating Tumor Cells
#136METHODS FOR DIAGNOSING CHRONIC DIARRHEA THROUGH PROTEIN SECRETION ANALYSIS
#137Devices and methods of cell capture and analysis
#138Antibody cocktail
#139Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
#140Methods and kits for the differential diagnosis of Alzheimer's disease versus frontotemporal dementia and for the diagnosis of frontotemporal dementia, comprising FAS-L and CK 18 as biomarkers
#141NECTIN-4 FOR TARGET GENES OF CANCER THERAPY AND DIAGNOSIS
#142BIOMARKER FOR DIAGNOSING PANCREATIC CANCER
#143Systems and Methods of Detecting and Demonstrating Hair Damage Via Detection of Protein Loss
#144COMPOSITION, KIT, AND METHOD FOR DIAGNOSING COLORECTAL CANCER OR OVARIAN CANCER
#145Systems and Methods of Detecting and Demonstrating Hair Damage Via Evaluation of Protein Fragments
#146Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
#147Biomarker-Based Methods For Formulating Compositions That Improve Skin Quality And Reduce The Visible Signs Of Aging In Skin
#148Methods for Detecting Tumor Origin Based on MUC1, MUC2, and CK-17 Expression Levels
#149Methods For Improving Skin Quality
#150Methods For Improving Skin Quality
#151Methods For Improving Skin Quality
#152Methods For Improving Skin Quality
#153Methods For Improving Skin Quality
#154Detection and monitoring of liver damage
#155ASC as a marker for lung cancer
#156Detection and monitoring of liver damage
#157Method for Assessing the Damage of Keratin Fibers
#158Methods for detecting fetal cells in the maternal blood
#159MICROCHIP FOR PROTEIN FIXATION
#160Circulating tumor cell assay
#161PROCESS
#162METHODS FOR DIAGNOSING CHRONIC DIARRHEA THROUGH PROTEIN SECRETION ANALYSIS
#163Measurement of nicotinamde N-methyl transferase in diagnosis of lung cancer
#164Method for diagnosing cardiovascular diseases
#165Biological markers predictive of anti-cancer response to kinase inhibitors
#166Methods and marker combinations for screening for predisposition to lung cancer
#167METHODS FOR DIAGNOSING CHRONIC DIARRHEA
#168Detection and monitoring of liver damage
#169CYFRA 21-1 as a marker for colorectal cancer
#170Cancer metastasis determination method
#171Novel Genes involved in Epidermal differentiation, and uses thereof
#172Epithelial cell specific growth factor keratinocyte growth factor (KGF)
#173Method for the determination of the composition of textile fibers
#174Method for screening an agent for preventing or ameliorating wrinkles
#175Multiplex in situ immunohistochemical analysis
#176METHOD OF DIAGNOSING CHRONIC DIARRHEA
#177Tissue diagnostics for ovarian cancer
#178Tissue diagnostics for breast cancer
#179Epithelial cell specific growth factor keratinocyte growth factor (KGF)
#180Assay of hair proteins
#181Method for the immunocytological or molecular detection of disseminated tumor cells from a body fluid and kit that is suitable therefor
#182Suprabasal breast cell with stem cell properties
#183Identifying candidate cells using image analysis
#184Convolutional neural networks for cancer diagnosis